ACI
GSK icon

AMP Capital Investors’s GSK GSK Stock Holding History

AMP Capital Investors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,949
Closed -$278K – 1278
2020
Q3 		$278K Hold
5,949
– – ﹤0.01% 1069
2020
Q2 		$303K Hold
5,949
– – ﹤0.01% 1022
2020
Q1 		$280K Sell
5,949
-21,372
-78% -$1.14M ﹤0.01% 990
2019
Q4 		$1.61M Buy
27,321
+2,608
+11% +$145K 0.01% 794
2019
Q3 		$1.31M Buy
24,713
+17,812
+258% +$916K 0.01% 826
2019
Q2 		$345K Sell
6,901
-21,906
-76% -$1.1M ﹤0.01% 1051
2019
Q1 		$1.51M Sell
28,807
-663
-2% -$33.1K 0.01% 800
2018
Q4 		$1.41M Buy
29,470
+5,464
+23% +$269K 0.01% 786
2018
Q3 		$1.22M Buy
24,006
+15,614
+186% +$793K 0.01% 844
2018
Q2 		$423K Sell
8,392
-3,606
-30% -$182K ﹤0.01% 1024
2018
Q1 		$591K Hold
11,998
– – ﹤0.01% 962
2017
Q4 		$532K Sell
11,998
-2,198
-15% -$102K ﹤0.01% 1014
2017
Q3 		$720K Hold
14,196
– – ﹤0.01% 946
2017
Q2 		$768K Sell
14,196
-6,457
-31% -$344K ﹤0.01% 905
2017
Q1 		$1.1M Hold
20,653
– – 0.01% 844
2016
Q4 		$992K Sell
20,653
-988
-5% -$48.8K 0.01% 873
2016
Q3 		$1.16M Sell
21,641
-100,035
-82% -$5.48M 0.01% 839
2016
Q2 		$6.46M Buy
121,676
+106,796
+718% +$5.63M 0.04% 408
2016
Q1 		$757K Hold
14,880
– – 0.01% 883
2015
Q4 		$763K Hold
14,880
– – 0.01% 902
2015
Q3 		$699K Buy
+14,880
New +$775K 0.01% 901
2014
Q3 		– Sell
-112,085
Closed -$7.54M – 1177
2014
Q2 		$7.54M Sell
112,085
-98,440
-47% -$6.66M 0.05% 423
2014
Q1 		$14.2M Buy
210,525
+204,709
+3,520% +$13.8M 0.1% 248
2013
Q4 		$386K Sell
5,816
-155,524
-96% -$10.1M ﹤0.01% 1041
2013
Q3 		$10.2M Sell
161,340
-210,901
-57% -$13.6M 0.08% 305
2013
Q2 		$23.3M Buy
+372,241
New +$23.6M 0.18% 127

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

AMP Capital Investors's GSK Position: Q4 2020 in Review

AMP Capital Investors sold out of GSK (GSK) in Q4 2020, closing a stake of 5,949 shares — an estimated $278K sold.

AMP Capital Investors first reported a position in GSK in Q2 2013 and held it in 26 quarters. The position peaked at $23.3M in Q2 2013. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • AMP Capital Investors reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • AMP Capital Investors sold 5,949 GSK shares in Q4 2020, an estimated $278K.
  • AMP Capital Investors first reported a position in GSK in Q2 2013 and held it in 26 quarters.
  • AMP Capital Investors's GSK position peaked at $23.3M in Q2 2013.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on AMP Capital Investors's 13F filing for Q4 2020, filed 12 Feb 2021.